Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrei I Chapoval

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Allergic inflammatory response to short ragweed allergenic extract in HLA-DQ transgenic mice lacking CD4 geneSvetlana P Chapoval, Koji Iijima, Eric V Marietta, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2014
The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) miceMichelle A Sallin, Xiaoyu Zhang, Edward C So, et al.
Blood|September 13, 2003
Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivoRyan A Wilcox, Koji Tamada, Dallas B Flies, et al.
Cancer Research|February 5, 2008
Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasionCarolina L Montes, Andrei I Chapoval, Jonas Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapyYue Zhang, Lukas W Pfannenstiel, Elzbieta Bolesta, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2002
Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patientsScott E Strome, Elizabeth Martin, Dallas Flies, et al.
The Journal of Clinical Investigation|March 6, 2002
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumorsRyan A Wilcox, Dallas B Flies, Gefeng Zhu, et al.
Immunity|June 24, 2003
B7-H4, a molecule of the B7 family, negatively regulates T cell immunityGabriel L Sica, In Hak Choi, Gefeng Zhu, et al.
Molecular Immunology|September 17, 2013
BTNL8, a butyrophilin-like molecule that costimulates the primary immune responseAndrei I Chapoval, Glennda Smithson, Linda Brunick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinomaAlan A Z Alexander, Amudhan Maniar, Jean-Saville Cummings, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
Allergic inflammatory response to short ragweed allergenic extract in HLA-DQ transgenic mice lacking CD4 geneSvetlana P Chapoval, Koji Iijima, Eric V Marietta, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2014
The anti-lymphoma activities of anti-CD137 monoclonal antibodies are enhanced in FcγRIII(-/-) miceMichelle A Sallin, Xiaoyu Zhang, Edward C So, et al.
Blood|September 13, 2003
Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivoRyan A Wilcox, Koji Tamada, Dallas B Flies, et al.
Cancer Research|February 5, 2008
Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasionCarolina L Montes, Andrei I Chapoval, Jonas Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapyYue Zhang, Lukas W Pfannenstiel, Elzbieta Bolesta, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 1, 2002
Reassessment of CD62L as a marker of pre-effector T cells in the tumor draining lymph nodes of head and neck cancer patientsScott E Strome, Elizabeth Martin, Dallas Flies, et al.
The Journal of Clinical Investigation|March 6, 2002
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumorsRyan A Wilcox, Dallas B Flies, Gefeng Zhu, et al.
Immunity|June 24, 2003
B7-H4, a molecule of the B7 family, negatively regulates T cell immunityGabriel L Sica, In Hak Choi, Gefeng Zhu, et al.
Molecular Immunology|September 17, 2013
BTNL8, a butyrophilin-like molecule that costimulates the primary immune responseAndrei I Chapoval, Glennda Smithson, Linda Brunick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinomaAlan A Z Alexander, Amudhan Maniar, Jean-Saville Cummings, et al.
Pageof 3